Rajesh Y, Biswas Angana, Mandal Mahitosh
School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Exp Cell Res. 2017 Oct 15;359(2):299-311. doi: 10.1016/j.yexcr.2017.08.032. Epub 2017 Aug 26.
Glial tumor is one of the intrinsic brain tumors with high migratory and infiltrative potential. This essentially contributes to the overall poor prognosis by circumvention of conventional treatment regimen in glioma. The underlying mechanism in gliomagenesis is bestowed by two processes- Extracellular matrix (ECM) Remodeling and Epithelial to mesenchymal transition (EMT). Heat Shock Family of proteins (HSPs), commonly known as "molecular chaperons" are documented to be upregulated in glioma. A positive correlation also exists between elevated expression of HSPs and invasive capacity of glial tumor. HSPs overexpression leads to mutational changes in glioma, which ultimately drive cells towards EMT, ECM modification, malignancy and invasion. Differential expression of HSPs - a factor providing cytoprotection to glioma cells, also contributes towards its radioresistance /chemoresistance. Various evidences also display upregulation of EMT and ECM markers by various heat shock inducing proteins e.g. HSF-1. The aim of this review is to study in detail the role of HSPs in EMT and ECM leading to radioresistance/chemoresistance of glioma cells. The existing treatment regimen for glioma could be enhanced by targeting HSPs through immunotherapy, miRNA and exosome mediated strategies. This could be envisaged by better understanding of molecular mechanisms underlying glial tumorigenesis in relation to EMT and ECM remodeling under HSPs influence. Our review might showcase fresh potential for the development of next generation therapeutics for effective glioma management.
胶质肿瘤是具有高迁移和浸润潜能的原发性脑肿瘤之一。这在本质上导致了胶质瘤总体预后较差,因为它能规避传统的治疗方案。胶质瘤发生的潜在机制由两个过程赋予——细胞外基质(ECM)重塑和上皮-间质转化(EMT)。热休克蛋白家族(HSPs),通常被称为“分子伴侣”,在胶质瘤中被证明上调。HSPs表达升高与胶质肿瘤的侵袭能力之间也存在正相关。HSPs的过表达导致胶质瘤发生突变,最终促使细胞发生EMT、ECM修饰、恶性转化和侵袭。HSPs的差异表达——一种为胶质瘤细胞提供细胞保护的因素,也导致了其放射抗性/化学抗性。各种证据还显示,多种热休克诱导蛋白(如HSF-1)可上调EMT和ECM标志物。本综述的目的是详细研究HSPs在导致胶质瘤细胞放射抗性/化学抗性的EMT和ECM中的作用。通过免疫疗法、miRNA和外泌体介导的策略靶向HSPs,可增强现有的胶质瘤治疗方案。通过更好地理解在HSPs影响下与EMT和ECM重塑相关的胶质肿瘤发生的分子机制,可以设想这一点。我们的综述可能会展示有效管理胶质瘤的下一代治疗方法开发的新潜力。